These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3631972)

  • 21. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo.
    Nagane M; Pan G; Weddle JJ; Dixit VM; Cavenee WK; Huang HJ
    Cancer Res; 2000 Feb; 60(4):847-53. PubMed ID: 10706092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.
    Lyu MA; Kurzrock R; Rosenblum MG
    Biochem Pharmacol; 2008 Feb; 75(4):836-46. PubMed ID: 18082672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
    Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H
    Anticancer Res; 2000; 20(2B):1237-44. PubMed ID: 10810427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
    Ning SC; Hahn GM
    Cancer Res; 1991 Nov; 51(21):5910-4. PubMed ID: 1718588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
    Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
    J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells.
    Petrova EE; Valyakina TI; Simonova MA; Komaleva RL; Khaidukov SV; Makarov EA; Blokhin DY; Ivanov PK; Andronova TM; Nesmeyanov VA
    Int Immunopharmacol; 2006 Sep; 6(9):1377-86. PubMed ID: 16846831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of methylprednisolone on antitumor effect of cis-diamminedichloroplatinum (II)].
    Lee K; Kubota T; Sawamara M; Kadowaki K; Kawamura E; Egawa S; Ishibashi A
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1444-9. PubMed ID: 6540069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synergistic antitumor effect of natural-human TNF and anticancer drugs.
    Itano S; Fuchimoto S; Orita K
    Hiroshima J Med Sci; 1987 Jun; 36(2):157-61. PubMed ID: 3654267
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
    Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
    Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
    Morimoto H; Yonehara S; Bonavida B
    Cancer Res; 1993 Jun; 53(11):2591-6. PubMed ID: 7684321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antitumor activity of recombinant human tumor necrosis factor (TNF)].
    Somura K; Nakano K; Abe M; Nakata K; Yoshida H
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):160-2. PubMed ID: 3966807
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside.
    Presant CA; Vietti TJ; Valeriote F; Coulter DM
    J Natl Cancer Inst; 1981 Dec; 67(6):1283-8. PubMed ID: 6171666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Potentiation of the cytotoxic effects of various anticancer drugs by interferon on human neoplastic cells (HeLa) in culture].
    Namba M; Yamamoto S; Tanaka H; Kanamori T; Nobuhara M; Kimoto T
    Gan To Kagaku Ryoho; 1983 May; 10(5):1308-12. PubMed ID: 6191681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antitumor activity of tumor necrosis factor (TNF) in vitro and in vivo].
    Haranaka K; Satomi N; Sakurai A
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1387-93. PubMed ID: 6742865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
    Mizutani Y; Yoshida O; Miki T; Bonavida B
    Clin Cancer Res; 1999 Sep; 5(9):2605-12. PubMed ID: 10499639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Consideration of simultaneous combination chemotherapy--employing a sensitivity test in Dunn osteosarcoma and NR fibrosarcoma by intra-test tube contact of tumor cell suspension, and subcutaneous inoculation].
    Inoue O; Ibaraki K; Shimabukuro H; Shingaki Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2781-7. PubMed ID: 2074388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.